SEARCH

SEARCH BY CITATION

References

  • Arrasate M. , Mitra S. , Schweitzer E. S. , Segal M. R. and Finkbeiner S. ( 2004 ) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death . Nature 431 , 805810 . DOI: 10.1038/nature02998
  • Blum D. , Galas M. C. , Pintor A. , Brouillet E. , Ledent C. , Muller C. E. , Bantubungi K. , Galluzzo M. , Gall D. , Cuvelier L. , Rolland A. S. , Popoli P. and Schiffmann S. N. ( 2003 ) A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists . J. Neurosci. 23 , 53615369 .
  • Calabresi P. , Centonze D. and Bernardi G. ( 2000 ) Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum . Neurology 55 , 12491255 .
  • Carter R. J. , Lione L. A. , Humby T. , Mangiarini L. , Mahal A. , Bates G. P. , Dunnett S. B. and Morton A. J. ( 1999 ) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation . J. Neurosci. 19 , 32483257 .
  • Cha J. H. , Kosinski C. M. , Kerner J. A. , Alsdorf S. A. , Mangiarini L. , Davies S. W. , Penney J. B. , Bates G. P. and Young A. B. ( 1998 ) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene . Proc. Natl Acad. Sci. USA 95 , 64806485 .
  • Chan E. Y. , Luthi-Carter R. , Strand A. , Solano S. M. , Hanson S. A. , DeJohn M. M. , Kooperberg C. , Chase K. O. , DiFiglia M. , Young A. B. , Leavitt B. R. , Cha J. H. , Aronin N. , Hayden M. R. and Olson J. M. ( 2002 ) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease . Hum Mol Genet 11 , 19391951 .
  • Cheng H. C. , Shih H. M. and Chern Y. ( 2002 ) Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade . J. Biol. Chem. 277 , 33 93033 942 .
  • Chern Y. , Chiou J. Y. , Lai H. L. and Tsai M. H. ( 1995 ) Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A . Mol Pharmacol. 48 , 18 .
  • Chern Y. , King K. , Lai H. L. and Lai H. T. ( 1992 ) Molecular cloning of a novel adenosine receptor gene from rat brain . Biochem. Biophys. Res. Commun 185 , 304309 .
  • Chern Y. , Lee E. H. , Lai H. L. , Wang H. L. , Lee Y. C. and Ching Y. H. ( 1996 ) Circadian rhythm in the Ca (2+)-inhibitable adenylyl activity of the rat striatum . FEBS Lett. 385 , 205208 .
  • Chu Y. Y. , Tu K. H. , Lee Y. C. , Kuo Z. J. , Lai H. L. and Chern Y. ( 1996 ) Characterization of the rat A2a adenosine receptor gene . DNA Cell Biol. 15 , 329337 .
  • Corsi C. , Melani A. , Bianchi L. and Pedata F. ( 2000 ) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats . Neuroreport 11 , 25912595 .
  • Couzin J. ( 2004 ) Huntington's disease. Unorthodox clinical trials meld science and care . Science 304 , 816817 .
  • Day Y. J. , Huang L. , McDuffie M. J. , Rosin D. L. YeH. , Chen J. F. , Schwarzschild M. A. , Fink J. S. , Linden J. and Okusa M. D. ( 2003 ) Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells . J. Clin. Invest 112 , 883891 .
  • Duan W. , Guo Z. , Jiang H. , Ware M. , Li X. J. and Mattson M. P. ( 2003 ) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice . Proc. Natl Acad. Sci. USA 100 , 29112916 .
  • Dunah A. W. , Jeong H. , Griffin A. , Kim Y. M. , Standaert D. G. , Hersch S. M. , Mouradian M. M. , Young A. B. , Tanese N. and Krainc D. ( 2002 ) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease . Science 296 , 22382243 .
  • Ehrlich M. E. , Conti L. , Toselli M. , Taglietti L. , Fiorillo E. , Taglietti V. , Ivkovic S. , Guinea B. , Tranberg A. , Sipione S. , Rigamonti D. and Cattaneo E. ( 2001 ) ST14A cells have properties of a medium-size spiny neuron . Exp Neurol. 167 , 215226 .
  • Ferrante R. J. , Andreassen O. A. , Jenkins B. G. , Dedeoglu A. , Kuemmerle S. , Kubilus J. K. , Kaddurah-Daouk R. , Hersch S. M. and Beal M. F. ( 2000 ) Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease . J. Neurosci. 20 , 43894397 .
  • Fink J. S. , Kalda A. , Ryu H. , Stack E. C. , Schwarzschild M. A. , Chen J. F. and Ferrante R. J. ( 2004 ) Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage . J. Neurochem. 88 , 538544 .
  • Fryer L. G. , Parbu-Patel A. and Carling D. ( 2002 ) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways . J. Biol. Chem. 277 , 25 22625 232 .
  • Garseth M. , Sonnewald U. , White L. R. , Rod M. , Zwart J. A. , Nygaard O. and Aasly J. ( 2000 ) Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease . J. Neurosci. Res. 60 , 779782 .
  • Glass M. , Dragunow M. and Faull R. L. ( 2000 ) The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA (A) receptor alterations in the human basal ganglia in Huntington's disease . Neuroscience 97 , 505519 .
  • Hansson O. , Petersen A. , Leist M. , Nicotera P. , Castilho R. F. and Brundin P. ( 1999 ) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity . Proc. Natl Acad. Sci. USA 96 , 87278732 .
  • Hardie D. G. , Carling D. and Carlson M. ( 1998 ) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67 , 821855 .
  • Hickey M. A. and Morton A. J. ( 2000 ) Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity . J. Neurochem. 75 , 21632171 .
  • Hong Y. H. , Varanasi U.S., Yang W. and Leff T. ( 2003 ) AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability . J. Biol. Chem. 278 , 27 49527 501 .
  • Huang N. K. , Lin Y. W. , Huang C. L. , Messing R. O. and Chern Y. ( 2001 ) Activation of protein kinase A and atypical protein kinase C by A (2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells . J. Biol. Chem. 276 , 13 83813 846 .
  • Hurlbert M. S. , Zhou W. , Wasmeier C. , Kaddis F. G. , Hutton J. C. and Freed C. R. ( 1999 ) Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes . Diabetes 48 , 649651 .
  • Jenkins B. G. , Klivenyi P. , Kustermann E. , Andreassen O. A. , Ferrante R. J. , Rosen B. R. and Beal M. F. ( 2000 ) Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice . J. Neurochem. 74 , 21082119 .
  • Klapstein G. J. , Fisher R. S. , Zanjani H. , Cepeda C. , Jokel E. S. , Chesselet M. F. and Levine M. S. ( 2001 ) Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice . J. Neurophysiol. 86 , 26672677 .
  • Laemmli , U. K. ( 1970 ) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature 227 , 680685 .
  • Lai H. L. , Yang T. H. , Messing R. O. , Ching Y. H. , Lin S. C. and Chern Y. ( 1997 ) Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response . J. Biol. Chem. 272 , 49704977 .
  • Lee Y. C. , Chien C. L. , Sun C. N. , Huang C. L. , Huang N. K. , Chiang M. C. , Lai H. L. , Lin Y. S. , Chou S. Y. , Wang C. K. , Tai M. H. , Liao W. L. , Lin T. N. , Liu F. C. and Chern Y. ( 2003 ) Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system . Eur J. Neurosci. 18 , 17861796 .
  • Lee E. H. , Liu S. P. , Lu K. T. and Lin W. R. ( 1992 ) Comparative studies of the neurotoxicity of MPTP in rats of different ages . Chin J. Physiol. 35 , 317336 .
  • Liu F. C. , Wu G. C. , Hsieh S. T. , Lai H. L. , Wang H. F. , Wang T. W. and Chern Y. ( 1998 ) Expression of type VI adenylyl cyclase in the central nervous system: implication for a potential regulator of multiple signals in different neurotransmitter systems . FEBS Lett. 436 , 9298 .
  • Lodi R. , Schapira A. H. , Manners D. , Styles P. , Wood N. W. , Taylor D. J. and Warner T. T. ( 2000 ) Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy . Ann. Neurol. 48 , 7276 .
  • Luesse H. G. , Schiefer J. , Spruenken A. , Puls C. , Block F. and Kosinski C. M. ( 2001 ) Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus . Behav. Brain Res. 126 , 185195 .
  • Luthi-Carter R. , Strand A. D. , Hanson S. A. , Kooperberg C. , Schilling G. , La Spada A. R. , Merry D. E. , Young A. B. , Ross C. A. , Borchelt D. R. and Olson J. M. ( 2002 ) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects . Hum Mol Genet 11 , 19271937 .
  • Mangiarini L. , Sathasivam K. , Seller M. , Cozens B. , Harper A. , Hetherington C. , Lawton M. , Trottier Y. , Lehrach H. , Davies S. W. and Bates G. P. ( 1996 ) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice . Cell 87 , 493506 .
  • Martindale D. , Hackam A. , Wieczorek A. , Ellerby L. , Wellington C. , McCutcheon K. , Singaraja R. , Kazemi-Esfarjani P. , Devon R. , Kim S. U. , Bredesen D. E. , Tufaro F. and Hayden M. R. ( 1998 ) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates . Nat Genet 18 , 150154 .
  • Meade C. A. , Deng Y. P. , Fusco F. R. , Del Mar. N. , Hersch S. , Goldowitz D. and Reiner A. ( 2002 ) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice . J. Comp Neurol. 449 , 241269 .
  • Morton A. J. and Leavens W. ( 2000 ) Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity . Brain Res. Bull. 52 , 5159 .
  • Ona V. O. , Li M. , Vonsattel J. P. , Andrews L. J. , Khan S. Q. , Chung W. M. , Frey A. S. , Menon A. S. , Li X. J. , Stieg P. E. , Yuan J. , Penney J. B. , Young A. B. , Cha J. H. and Friedlander R. M. ( 1999 ) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease . Nature 399 , 263267 .
  • Perutz . M. F. ( 1999 ) Glutamine repeats and neurodegenerative diseases: molecular aspects . Trends Biochem. Sci. 24 , 5863 .
  • Podolsky S. , Leopold N. A. and Sax D. S. ( 1972 ) Increased frequency of diabetes mellitus in patients with Huntington's chorea . Lancet 1 , 13561358 .
  • Pratley R. E. , Salbe A. D. , Ravussin E. and Caviness J. N. ( 2000 ) Higher sedentary energy expenditure in patients with Huntington's disease . Ann. Neurol. 47 , 6470 .
  • Rutter G. A. , Da Silva Xavier G. and Leclerc I. ( 2003 ) Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis . Biochem. J. 375 , 116 .
  • Spektor B. S. , Miller D. W. , Hollingsworth Z. R. , Kaneko Y. A. , Solano S. M. , Johnson J. M. , Penney J. B. Jr , Young A. B. and Luthi-Carter R. ( 2002 ) Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease . Brain Res. Mol Brain Res. 102 , 118128 .
  • Tanaka M. , Machida Y. , Niu S. , Ikeda T. , Jana N. R. , Doi H. , Kurosawa M. , Nekooki M. and Nukina N. ( 2004 ) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease . Nat Med. 10 , 148154 .
  • The Huntington's Disease Collaborative Research Group. ( 1993 ) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes . Cell 72 , 971983 .
  • Tsuboi T. , da Silva Xavier G. , Leclerc I. and Rutter G. A. ( 2003 ) 5′-AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics . J. Biol. Chem. 278 , 52 04252 051 .
  • Varani K. , Abbracchio M. P. , Cannella M. , Cislaghi G. , Giallonardo P. , Mariotti C. , Cattabriga E. , Cattabeni F. , Borea P. A. , Squitieri F. and Cattaneo E. ( 2003 ) Aberrant A2A receptor function in peripheral blood cells in Huntington's disease . Faseb J. 17 , 21482150 .
  • Varani K. , Rigamonti D. , Sipione S. , Camurri A. , Borea P. A. , Cattabeni F. , Abbracchio M. P. and Cattaneo E. ( 2001 ) Aberrant amplification of A (2A) receptor signaling in striatal cells expressing mutant huntingtin . Faseb J. 15 , 12451247 .
  • Vonsattel J. P. , Myers R. H. , Stevens T. J. , Ferrante R. J. , Bird E. D. and Richardson E. P. Jr ( 1985 ) Neuropathological classification of Huntington's disease . J. Neuropathol Exp Neurol. 44 , 559577 .
  • Walker B. A. , Rocchini C. , Boone R. H. , Ip S. and Jacobson M. A. ( 1997 ) Adenosine A2a receptor activation delays apoptosis in human neutrophils . J. Immunol. 158 , 29262931 .
  • Waters N. J. , Holmes E. , Waterfield C. J. , Farrant R. D. and Nicholson J. K. ( 2002 ) NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate . Biochem. Pharmacol. 64 , 6777 .
  • Winder W. W. , Wilson H. A. , Hardie D. G. , Rasmussen B. B. , Hutber C. A. , Call G. B. , Calyton R. D. , Conley L. M. , Yoon S. and Zhou B. ( 1997 ) Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase . A. J. Appl. Physiol. 82 , 219225 .